Peer Review History

Original SubmissionMarch 4, 2024
Decision Letter - Chalachew Kassaw Demoze, Editor

PONE-D-24-07891Depressive Symptoms and its Associated Factors among Health Care Workers in Saint Paul’s Hospital Millennium Medical College, Ethiopia.PLOS ONE

Dear Dr. Tesema

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 08 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Chalachew Kassaw Demoze, Msc

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

The American Journal Experts (AJE) (https://www.aje.com/) is one such service that has extensive experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. Please note that having the manuscript copyedited by AJE or any other editing services does not guarantee selection for peer review or acceptance for publication. 

Upon resubmission, please provide the following: 

● The name of the colleague or the details of the professional service that edited your manuscript

● A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

● A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

5. Please include a separate caption for each figure in your manuscript.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear reviwer, We would like to acknowledge your work.

Hereunder, I suggest some corrections to your manuscript.

1. Your study topic is extensively researched, so what makes your tudy unique, novel and relevant?

2. Why do you want to do ordinal rather than dichotomous or logistic regression analysis?

3. it is better to write an assumption of ordinal regression analysis

4. It is better to write the data collection tool descriptions you used to assess independent variables.

5. it is better to write concrete reasons for the study result difference ( "the inclusion criteria, sample size and instrument used " reasons might not be statistically acceptable).

6. it is better to write a specific recommendation for each stduy finding to the institution (St. Paul paul college)

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors raised important topic but need to solidify their study on research gaps and the need of this study and why they need to do it

Abstract:

Background: It is better to describe the burden of depression overall and targeting the health care worker rather than putting the definition

Conclusion: Do you think this recommendation is feasible and how can MOH know this about healthcare workers and we all know stigma faced people with mental illness.

Background

� Paragraph 2 needs synthesis and shortening also you could consider making it two paragraphs

� Need to work on literature gap and novelty

� what makes your study different if already done in Ethiopia

� what are the research gaps and please back it up with evidences

methodology

� What is the reason using power calculation each factor?

� it’s better to describe the factors and dependent variable in separate heading

� describe the value of multicoliniarity and model fitness the exact statically number

Results

� How come you used cut of point of 5 as depression as the score depression is not like that but showing the severity that made the prevalence higher

� please show the p value in the table

� the discussion needs to be synthesize the argument and supporting literature

� More to discuss the reason behind it

� you need to re-run the prevalence i don't think there is higher prevalence because so you used 5 as cut point because you include mild

Reviewer #2: - The authors refers to Depressive disorder, but also Depression, Depressive symptoms, Depressed symptoms, Major depressive disorder etc… interchangeably, which can be confusing to the reader. These phenomena are not the same thing, and it is advisable to use one term consistently throughout the abstract and main text. In this case, either Depression or Depressive symptoms.

- In Paragraph 3 of the background - it is important to clarify that those studies were also done among HCW. Only the first sentence mentions HCW.

- The last paragraph of the background is too repetitive. The aim of study only needs to be stated once.

- In the sample size section, it is not clear how the authors came up with this method of sample size calculation. If this is a pre-existing method then a citation needs to be added, otherwise if this is an entirely new method of size calculation that also needs to be stated.

- In the Statistic Analysis, name should be Microsoft Excel, and mention the version used

- For the results, the authors started very well using past tense (were, was) but then later on switched to present tense (are, is, has). When writing results and discussion, the standard rule is to use past tense because we are mentioning what was found at the time of data collection, not now.

- Decide whether you want to use the name in full, or abbreviation SPHMMC, but not both

- What do the authors think about HCW responding to questions about suicide attempts, and chronic health issues? Could this be limitation? How did they address it?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Kim Madundo

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-24-07891-1_commented.pdf
Attachment
Submitted filename: Reviewer comments.docx
Revision 1

Response to reviewers

Reviewer #1:

1. The authors raised important topic but need to solidify their study on research gaps and the need of this study and why they need to do it

Response: Health care workers working in general set-up (non-front line) are susceptible to mental illness specifically depression. But research done among health care worker on depression among those whose working condition as non-frontline (general health care setup) is limited. So, this study helps to fill the above research gap by studying prevalence and factor associated with depression among health care workers in SPHMMC.

2. Abstract:

Background: It is better to describe the burden of depression overall and targeting the health care worker rather than putting the definition

Response: We did a revision accordingly (see Abstract, lines 2-5)

Conclusion: Do you think this recommendation is feasible and how can MOH know this about healthcare workers and we all know stigma faced people with mental illness.

Response: we added descriptions accordingly (Abstract lines 25-28)

3. Background

Paragraph 2 needs synthesis and shortening also you could consider making it two paragraphs

Response: we had split this paragraph into two (background paragraph 2-3)

4. Need to work on literature gap and novelty

Response: we added a reason for literature gabs (page 2, last paragraph of background line 12-17)

5. what makes your study different if already done in Ethiopia

Response: the available literature in Ethiopia mainly focused on depression among front line HCWs during COVID-19.

6. what are the research gaps and please back it up with evidences

Response: As stated on page 2, lines 12-17, the most recent available literature in Ethiopia mainly focused on depression among front line HCWs during COVID-19. Research done among HCWs working in general set up is limited in Ethiopia as well as in study area. This shows that there is literature gap in the area related to HCWs working as non-front line. (see reference listed 19-22)

7. Methodology

�What is the reason using power calculation each factor?

Response: Sample size calculations are used to determine either the sample size required to give a specified power, or the power implied by a specified sample size. Thus, sample size calculations need to be undertaken prior to a study to avoid both the wasteful consequences of under-powering or of overpowering. Further, in this study we planned to perform a test of hypothesis comparing the proportions, with an ordered categorical outcome, where analysis is by the proportional odds model. Studies that use small samples not being able to demonstrate differences or associations which really do exist. Such studies are ‘under-powered’, not possessing sufficient statistical power to detect the effects they set out to detect. The statistical power of a study builds in a safety margin to avoid generalizing false positive results which could have expensive consequences. A non-significant finding of a study may thus simply reflect the inadequate power of the study to detect differences or associations at levels which are conventionally accepted as statistically significant. In this study, the target power is 80%, meaning that a study has an 80% likelihood of detecting an association which really exists.

8. it’s better to describe the factors and dependent variable in separate heading

Response: We added descriptions for both dependent and independent factors separately. (methods, page 4 lines 5-116 and page 5 lines 1-5)

9. describe the value of multicollinearity and model fitness the exact statically number

Response: We had added description about the cutoff points to multicollinearity test and overall goodness of fit test. (Statistical analysis: page 6 lines 16-22)

10. Results

How come you used cut of point of 5 as depression as the score depression is not like that but showing the severity that made the prevalence higher

Response: Based on recommendation, we used cutoff point of ≥10 to show the prevalence of depression. Using cutoff point ≥10 for cases on PHQ-9, the prevalence of depression among HCWs in SPHMMC becomes 21. 9%, (95%CI: 18% ,27.76%).

11. Please show the p value in the table

Response: Confidence intervals are preferable to p-values, as they tell us the range of possible effect sizes compatible with the data. Further, confidence interval that excludes 1 reveals significant association. P-values simply provide a cut-off beyond which we assert that the findings are 'statistically significant. Thus, we used notation to show the strength of association to those significant variables (see bottom of Table 6). Also, we added p-values in this revised version.

12. the discussion needs to be synthesized the argument and supporting literature. More to discuss the reason behind it

Response: we did edition and added a reason in the revised version accordingly.

13. you need to re-run the prevalence i don't think there is higher prevalence because so you used 5 as cut point because you include mild.

Response: We used the classification as severe depression, moderate depression, and mild depression only to show the level of variation in the depression status. This is to show the variability as we move from lower level to higher level depression status. But based on the cutoff point ≥10 for cases on PHQ-9, the prevalence of depression among HCWs in SPHMMC was found 21. 9%, (95%CI: 18% ,27.76%). Concerning the severity, 9.3% had severe depression, and 12.5% had moderate depression, while 34.6% had mild depression

Reviewer #2:

1. The authors refer to Depressive disorder, but also Depression, Depressive symptoms, Depressed symptoms, Major depressive disorder etc… interchangeably, which can be confusing to the reader. These phenomena are not the same thing, and it is advisable to use one term consistently throughout the abstract and main text. In this case, either Depression or Depressive symptoms.

Response: It is depression, we did corrections throughout the document.

2. In Paragraph 3 of the background - it is important to clarify that those studies were also done among HCW. Only the first sentence mentions HCW.

Response: We added description on paragraph 4-line number 5 and 8 as if those study were done among HCWs.

3. The last paragraph of the background is too repetitive. The aim of study only needs to be stated once.

Response: we did corrections in the revised version

4. In the sample size section, it is not clear how the authors came up with this method of sample size calculation. If this is a pre-existing method then a citation needs to be added, otherwise if this is an entirely new method of sample size calculation that also needs to be stated.

Response: Sample size calculations are used to determine either the sample size required to give a specified power, or the power implied by a specified sample size. Thus, sample size calculations need to be undertaken prior to a study to avoid both the wasteful consequences of under-powering or of overpowering. Further, in this study we planned to perform a test of hypothesis comparing the proportions, with an ordered categorical outcome, where analysis is by the proportional odds model. Studies that use small samples not being able to demonstrate differences or associations which really do exist. Such studies are ‘under-powered’, not possessing sufficient statistical power to detect the effects they set out to detect. The statistical power of a study builds in a safety margin to avoid generalizing false positive results which could have expensive consequences. A non-significant finding of a study may thus simply reflect the inadequate power of the study to detect differences or associations at levels which are conventionally accepted as statistically significant. In this study, the target power is 80%, meaning that a study has an 80% likelihood of detecting an association which really exists. (See Whitehead J. Sample size calculations for ordered categorical data. Stat Med. 1993 Dec 30;12(24):2257-71. Erratum in: Stat Med 1994 Apr 30;13(8):871. PMID: 8134732).

5. In the Statistic Analysis, name should be Microsoft Excel, and mention the version used

Response: it is Microsoft Excel version 19

6. For the results, the authors started very well using past tense (were, was) but then later on switched to present tense (are, is, has). When writing results and discussion, the standard rule is to use past tense because we are mentioning what was found at the time of data collection, not now.

Response: We did extensive language edition in the revised version.

7. Decide whether you want to use the name in full, or abbreviation SPHMMC, but not both

Response: We had corrected in the revised version

8. What do the authors think about HCW responding to questions about suicide attempts, and chronic health issues? Could this be limitation? How did they address it?

Response: Yes, it could be limitation and we added it under limitation of study

Additional Editor Comments:

1. Your study topic is extensively researched, so what makes your study unique, novel and relevant?

Response: What makes this study novel, unique and relevant is study being conducted among HCWs working in general working setup (in all working department) rather than frontline HCWs. Further, the previous studies consider to model only the presence of depression as yes or no. Even if the individual has depression the level of severity also varies among individuals. Thus, this study tries to fill this research gab.

2. Why do you want to do ordinal rather than dichotomous or logistic regression analysis?

Response: we added a reason for the use of ordinal logistic regression model in the revised manuscript (page 6, lines 3-11 and page 6, lines 16-22)

3. it is better to write an assumption of ordinal regression analysis

Response: we added the assumptions of our model in the revised revision of the manuscript (page 6, lines 8-11)

4. It is better to write the data collection tool descriptions you used to assess independent variables.

Response: Sociodemographic variables, psycho-social factors, physical health status, and health professional status were assessed by HCWs response to yes/no options and among listed category for each question. To assess social support Oslo-3-item social support scale was used and those with score of 3-8 was classified as poor social support, 9-11 as moderate social support and 12-14 as strong social support. Page 5, lines 11-15. (See Kocalevent RD, Berg L, Beutel ME, Hinz A, Zenger M, Härter M et al. Social support in the general population : standardization of the Oslo social support scale ( OSSS-3 ). BMC Psychology. 2018;6(31):1–8.) Job satisfaction was measured by using short form twenty items Minnesota Satisfaction Questionnaire each scored 5-point Likert scale with 1 denoting strongly dissatisfied and 5 denoting strongly satisfied. Overall job satisfaction was estimated by taking the sum score of all the subscales. HCWs who scored a value of 62 and below was considered as dissatisfied and those who scored greater than 62 was considered as satisfied (Reference_ Weiss J. David, Rene D V. Manual for the Minnesota Satisfaction Questionnaire.pdf. 1967. p. 110–1). This description is added in revised version page 5-line number 15-20.

5. it is better to write concrete reasons for the study result difference (“the inclusion criteria, sample size and instrument used " reasons might not be statistically acceptable).

Response: correction done in the revised version

6. it is better to write a specific recommendation for each study finding to the institution (St. Paul college)

Response: We added recommendation to the institution (SPHMMC) in the abstract as well as conclusion part.

NB. We added reference and cited accordingly. As a result, our reference list increased from 46 to 52.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Shegaw Tesfa Mengist, Editor

Depression and its Associated Factors among Health Care Workers in Saint Paul’s Hospital Millennium Medical College, Ethiopia.

PONE-D-24-07891R1

Dear Authors;

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Shegaw Tesfa Mengist

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Kim Madundo

**********

Formally Accepted
Acceptance Letter - Shegaw Tesfa Mengist, Editor

PONE-D-24-07891R1

PLOS ONE

Dear Dr. Tesema,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Mr. Shegaw Tesfa Mengist

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .